Jupiter Bioscience Ltd has announced that the Board of Directors of the Company at its meeting held on May 28, 2007, has allotted 31,77,500 Equity Share Warrants to M/s. Ranbaxy Laboratories Ltd on a preferential basis representing approximately 14.91% of the expanded issued Share Capital of the Company at a price of Rs 147/- per Equity Share Warrant.
The said Equity Share Warrants convertible into Equity shares within a period of 18 months from the date of allotment OR at the time of exercise of option by M/s. Ranbaxy Laboratories Ltd which ever is earlier. The Company has already received 20% of the total consideration up front.
The stock was trading at Rs.179.75, down by Rs.5.85 or 3.15%. The stock hit an intraday high of Rs.188.45 and low of Rs.178.65. The total traded quantity was 285667 compared to 2 week average of 326585.